Target intelligence / Profile preview

Prostaglandin E receptor 4 pseudogene 2 (PTGER4P2)

Target: PTGER4P2
Molecular classification: Pseudogene

Overview

Prostaglandin E receptor 4 pseudogene 2 (PTGER4P2) is a pseudogene annotated in the human genome. It is named due to its sequence similarity to the prostaglandin E receptor 4 (PTGER4), which is a functional GPCR involved in prostaglandin signaling; however, PTGER4P2 itself does not encode a functional protein product. There is no evidence that it acts as a receptor, enzyme, or participates in signaling or pathological pathways. As a pseudogene, it may represent a noncoding genomic element or a relic of gene duplication or retrotransposition events and is not used as a therapeutic target[2].

Other names: PTGER4P2prostaglandin E receptor 4 pseudogene 2

Beyond the preview

Go deeper on Prostaglandin E receptor 4 pseudogene 2 (PTGER4P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prostaglandin E receptor 4 pseudogene 2 (PTGER4P2).

Explore the full profile